RecruitingNot ApplicableNCT07429955

Impact of Pre-operative Sarcopenia on Functional Recovery After Hip Arthroplasty in Older Adults


Sponsor

University Hospital, Montpellier

Enrollment

20 participants

Start Date

Aug 17, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This single-centre, exploratory study at Montpellier University Hospital will investigate whether having low muscle mass and strength before hip-replacement surgery, a condition called sarcopenia, impact the return to everyday independence in people aged 75 years or older. About 20 volunteers, scheduled for surgery because of a recent femoral-neck fracture or severe arthritis that no longer responds to usual care, will give consent, answer brief health questionnaires, attempt simple walking and chair-rise tests if possible, and provide a small blood sample. While they are already under anaesthesia for their planned operation, the surgical team will take a tiny muscle sample through the same incision, so no extra cuts are needed. During the hospital stay or shortly after discharge, each participant will have a painless MRI scan of the thigh muscles and a very-low-dose bone scan (DXA) to measure muscle and bone health. The research team will then telephone participants at 3 and 6 months to ask about daily activities, walking ability, and any complications. The study lasts about six months for each person and does not alter their usual medical or rehabilitation care. Potential benefits include close follow-up, personalised feedback on muscle and bone results, and helping doctors learn whether pre-surgery muscle weakness predicts slower recovery-information that could guide future, more personalised exercise and nutrition programs. Extra study procedures carry only minimal risks: a routine blood draw, scans with none (MRI) or very little (DXA) radiation, and a muscle biopsy taken during surgery. Taking part is entirely voluntary, and participants may withdraw at any time without affecting their current or future care. The whole project will run for 18 months.


Eligibility

Min Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a biological treatment called Blood sampling, a biological treatment called Collection of joint samples derived from surgical waste, and others for people with hip fracture surgeries, osteoarthritis (oa), and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 75 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURETotal hip replacement

Hip replacement is a surgical procedure performed as part of routine care for patients with a fracture of the upper end of the femur or severe osteoarthritis of the hip.

BIOLOGICALBlood sampling

Four heparinized tubes of 5 ml of blood will be collected from each patient at inclusion. All blood samples will be stored in a biobank for subsequent analyses targeting biomarkers potentially associated with sarcopenia and muscle regeneration.

BIOLOGICALMuscle biopsies

Performed during hip arthroplasty

BIOLOGICALCollection of joint samples derived from surgical waste

Performed during hip arthroplasty

RADIATIONDXA

Within 15 days following the surgical procedure, during hospitalization/rehabilitation

OTHERMRI

Within 15 days following the surgical procedure, during hospitalization/rehabilitation

OTHERHandgrip strength test

Measurement of handgrip strength using a hand dynamometer


Locations(1)

University Hospital

Montpellier, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07429955


Related Trials